476310·Stock-Sector-Healthcare
RISE Global Obesity Industry TOP2+
Introduction
The RISE Global Obesity Industry TOP2+ ETF seeks to provide investment results that, before expenses, correspond generally to the price and yield performance of the KEDI Global Obesity Care Industry Top2+ Index(Price Return)
Investment Points
ETF Investing in Key Companies for Obesity Treatment, a Global Megatrend
Benchmark Index
KEDI Global Obesity Care Industry Top2+ Index(Price Return)
Benchmark Index Description
This index invests in key companies related to the obesity industry, a global megatrend. It allocates 28% each to Eli Lilly (LLY) and Novo Nordisk (NVO), the first movers in the obesity treatment market, and it is composed of other global pharmaceutical companies and fitness-related companies weighted by market capitalization.
Issuer
KB Asset Management
Brand
RISE
Total Fee
0.35
Listing Date
2024-02-27
International Securities Code
KR7476310008
Market Information
Market Capitalization
4,666,750,000KRW
Transaction Amount
53,257,387KRW
Trading Volume
6,270
Shares Outstanding
550,000
NAV
8,559
52-Week High
11,700KRW
52-Week Low
8,420KRW